Incidence and Prognostic Value of TP53, STK11, and KEAP1 Mutations Between &lt;i&gt;De Novo&lt;/i&gt; Versus Recurrent Actionable Mutation-Negative Non-Small Cell Lung Cancer: A Single-Center Retrospective Study. This evidence concerns the gene TP53 and non-small cell lung carcinoma.